Epilepsy in the elderly

Expert Review of Neurotherapeutics

Volumn 10, Issue 12, 2010, Pages 1899-1910

  Johnston, Ann ^a,b   Smith, Phil E M ^b,c  

^a MORRISTON HOSPITAL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

comorbidities; diagnosis; drug interactions; elderly; epilepsy; polypharmacy

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DIGOXIN; DIURETIC AGENT; ETIRACETAM; GABAPENTIN; GINKGO BILOBA EXTRACT; HARKOSERIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; LEVODOPA; NEUROLEPTIC AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

ADD ON THERAPY; AGING; ALLERGIC RASH; ALZHEIMER DISEASE; ATAXIA; BEHAVIOR DISORDER; BLOOD EXAMINATION; BRAIN CONTUSION; BRAIN TUMOR; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG EXCRETION; DRUG METABOLISM; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC STATE; EXTRAPYRAMIDAL SYMPTOM; FOCAL EPILEPSY; GASTROINTESTINAL QUALITY OF LIFE INDEX; GINKGO BILOBA; GRAND MAL SEIZURE; GROUPS BY AGE; HEART ARRHYTHMIA; HUMAN; HYPONATREMIA; MENTAL DISEASE; MIGRAINE; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROPATHIC PAIN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYPHARMACY; PR INTERVAL; PRESCRIPTION; PREVALENCE; PROGNOSIS; PSYCHOSIS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STROKE; SUBDURAL HEMATOMA; TRANSIENT ISCHEMIC ATTACK; TRAUMATIC BRAIN INJURY; TREMOR; UNCONSCIOUSNESS; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

AGED; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; HUMANS; PROGNOSIS; QUALITY OF LIFE;

EID: 78649496865     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.170     Document Type: Review

References (73)

1. Leppik IE. Introduction to the International Geriatric Epilepsy Symposium (IGES). Epilepsy Res. 68(Suppl. 1), S1-S4 (2006).
2. Hauser WA. Seizure disorders: the changes with age. Epilepsia 33(Suppl. 4), S6-S14 (1992).
3. Cockerell OC, Eckle I, Goodridge DM et al. Epilepsy in a population of 6000 re-examined: secular trends in frst attendance rates, prevalence, and prognosis. J. Neurol. Neurosurg. Psychiatry 58, 570-576 (1995).
4. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population based studies from Rochester Minnesota. Mayo Clin. Proc. 71, 576-586 (1996).
5. Tallis R. Conference Report. The British Geriatric Society: the second annual cardiovascular section SpR meeting. Geriatr. Med. 37, S1-S4 (2007).
6. Hopkins A, Garman A, Clarke C. The frst seizure in adult life: value of clinical features, electroencephalography and computerised scanning in prediction of seizure recurrence. Lancet 331, 721-726 (1988).
7. Wallace H, Shorvon S, Tallis R. Age-specifc incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specifc fertility rates of women with epilepsy. Lancet 352, 1970-1973 (1998).
8. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 32, 429-445 (1991).
9. Schachter SC, Crammer WG, Thompson GD et al. An evaluation of antiepileptic drug therapy in nursing facilities. J. Am. Geriatr. Soc. 46(9), 1137-1141 (1998).
10. Lhatoo SD, Johnson AL, Goodridge DH, Macdonald BK, Sander JW, Shorvon SD. Mortality in epilepsy in the frst 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann. Neurol. 49, 336-344 (2001).
11. Treiman DM. Electroclinical features of status epilepticus. J. Clin. Neurophysiol. 12, 343-362 (1995).
12. Lees A. Retrospective study of seizure-related injuries in older people: a 10-year observation. Epilepsy Behav. DOI: 10.1016/j.yebeh.2010.08.021 (2010) (Epub ahead of print).
13. Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol. 8, 1019-1030 (2009).
14. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester Minnesota: 1935-1984. Epilepsia 34, 453-468 (1993).
15. Pugh MJ, Knoefel JE, Mortensen EM, Amuan ME, Berlowitz DR, Van Cott AC. New-onset epilepsy risk factors in older veterans J. Am. Geriatr. Soc. 57(2), 237-242 (2009).
16. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 46, 350-355 (1996).
17. Van Cott AC. Epilepsy and EEG in the elderly. Epilepsia 43(Suppl. 3), 94-102 (2002).
18. Loiseau P. Pathological processes in the elderly and their association with seizures. In: Seizures and Epilepsy in the Elderly. Rowan A, Ransay R (Eds). Butterworth-Heinemann, MA, USA, 63-85 (1997).
19. Clearly P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 363, 1184-1186 (2004).
20. McAreavey MJ, Ballinger BR, Fenton GW. Epileptic seizures in elderly patients with dementia. Epilepsia 33, 657-660 (1992).
21. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Epileptic seizures in elderly patients with dementia. Dementia and adult-onset unprovoked seizures. Neurology 46,727-730 (1996).
22. Hommet C, Mondon K, Camus V, De Toffol B, Constan S. Epilepsy and dementia in the elderly. Dement. Geriatr. Cogn. Disord. 25, 293-300 (2008).
23. Scarmeas N, Honig LS, Choi H et al. Seizures in Alzheimer disease; who, when and how common? Arch. Neurol. 66, 992-997 (2009).
24. Hiyoshi T, Yagi K. Epilepsy in the elderly. Epilepsia 41 (Suppl. 9), 31-35 (2004).
25. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 338, 20-24 (1998).
26. Roberts M, Godfrey J, Caird F. Epileptic seizures in the elderly: aetiology and type of seizure. Age Ageing 11, 24-28 (1982). (Pubitemid 12165648)
27. Sundaram MB. Aetiology and patterns of seizures in the elderly. Neuroepidemiology 8, 234-238 (1989).
28. Lyman LM, Lyons MK, Drakowski JF et al. Frequency of seizures in patients with newly diagnosed brain tumours; a retrospective review. Clin. Neurol. Neurosurg. 109, 634-638 (2007).
29. Ettinger AB, Copeland LA, Zeber JE, Pugh MJ. Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals? Epilepsy Behav. 17, 70-74 (2010).
30. Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 331, 1317-1322 (2005).
31. Franson KL, Hay DP, Neppe V et al. Drug induced seizures in the elderly: causative agents and optimal management. Drugs Aging 7, 38-48 (1995).
32. Ramsay RE, Pryor F. Epilepsy in the elderly. Neurology 55, S9-S14; discussion S54-S58 (2000).
33. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating elderly patients with epilepsy. Neurology 46, 727-730 (1996).
34. Stephen LJ, Brodie MJ, Epilepsy in elderly people. Lancet 355, 1441-1446 (2000).
35. Garrard J, Harms S, Hardie N et al. Antiepileptic drug use in nursing home admissions. Ann. Neurol. 54, 75-85 (2003). (Pubitemid 36764983)
36. Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE. Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder. Epilepsia 2, 323-329 (2006).
37. Oteri A, Trifrò G, Gagliostro MS et al. Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007. Br. J. Clin. Pharmacol. 70(4), 514-522 (2010).
38. Pugh MJ, Cramer J, Knoefel J, Charbonneau A, Mandell A, Kazis L, Berlowitz D. Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy. J. Am. Geriatr. Soc. 52, 417-422 (2004).
39. Brodie MJ, Overstall PW, Giorgi L; the UK Lamotrigine Elderly Study Group. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 37, 81-87 (1999).
40. Saetre E, Perucca E, Isojarvi J, Gjerstad L; on behalf of the LAM 40089 Study Group. An International multicenter randomised double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy. Epilepsia 48, 1292-1302 (2007).
41. Rowan AJ, Ramsay RE, Collins JF et al. New onset geriatric epilepsy: a randomised study of gabapentin, lamotrigine and carbamazepine. Neurology 64, 1868-1873 (2005).
42. Saetre E, Abdelnoor M, Perucca E, Taubøll E, Isojärvi J, Gjerstad L. Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age. Epilepsy Behav. 17, 395-401 (2010).
43. Sajatovic M, Ramsay E, Nanry K, Thompson T. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int. J. Geriatr. Psychiatry 22, 945-950 (2007).
44. Evans BK, Kustra RP, Hammer AE. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Am. J. Geriatr. Pharmacother. 5, 112-119 (2007).
45. Giorgi L, Gomez G, O'Neill F, Hammer AE, Risner M. The tolerability of lamotrigine in elderly patients with epilepsy. Drugs Aging 18, 621-630 (2001).
46. Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, Lampl Y. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clin. Neuropharmacol. 30, 189-195 (2007).
47. Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. Epilepsy Behav. 17, 461-466 (2010).
48. Arif H, Buchsbaum R, Pierro J et al. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arch. Neurol. 67, 408-415 (2010).
49. Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of carbamazepine, gabapentin, lamotrigine, oxcarbazapine or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369, 1000-1015 (2007).
50. Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of vaproate, lamotrigine, or topiramate for generalised and unclassifable epilepsy: an unblinded randomised controlled trial. Lancet 369, 1016-1026 (2007).
51. Perucca E, Berlowitz, Dirnbaum A. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res. 68(Suppl.), S49-S63 (2006).
52. Ahn JE, Cloyd JC, Brundage RC et al. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy. Neurology 1, 38-43 (2008).
53. Pugh MJ, Vancott AC, Steinman MA et al. Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications. J. Am. Geriatr. Soc. 58(3), 465-471 (2010).
54. Gidal BE, French JA, Grossman P, Le Teuff G. Assessment of potential drug interactions in patients with epilepsy: impact of age and sex. Neurology 72(5), 419-425 (2009).
55. Marson A, Jacoby A, Johnson A et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures; a randomised controlled trial. Lancet 365, 2007-2013 (2005).
56. Musicco M, Beghi E, Solari A, Viani F. Treatment of frst tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 49, 991-998 (1997).
57. Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 5(Suppl. 2), S41-S47 (2004).
58. Ucar M, Neuvonen M, Luurila H, Dahlqvist R, Neuvonen PJ, Mjörndal T. Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid Eur. J. Clin. Pharmacol. 59(12), 879-882 (2004).
59. Fife TD, Blum D, Fisher RS. Measuring the effects of antiepileptic medications on balance in older people. Epilepsy Res. 70(2-3), 103-109 (2006).
60. Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF, Mattson RH. Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch. Neurol. 53(10), 1008-1016 (1996).
61. Patsalos PN, Fröscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 43(4), 365-385 (2002).
62. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2(8), 473-481 (2003). (Pubitemid 36876104)
63. Manon-Espaillat R, Burnstine TH, Remler B, Reed RC, Osorio I. Antiepileptic drug intoxication: factors and their signifcance. Epilepsia 32(1), 96-100 (1991).
64. Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol. Scand. 108(Suppl.), 33-36 (2003).
65. Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav. 2, 324-329 (2009).
66. Beghi E, Tomini C. Surgery for epilepsy: assessing evidence from observational studies. Epilepsy Res. 70, 97-102 (2006).
67. Gallo BV. Epilepsy, surgery and the elderly. Epilepsy Res. 68(Suppl. 1), S83-S86 (2006).
68. Grivas A, Schramm J, Krai T et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia 8, 1364-1372 (2006).
69. Boon P, Vonck K, De RJ, Caemaert J. Vagal nerve stimulation for refractory epilepsy. Seizure 11(Suppl. A), 448-455 (2002). (Pubitemid 34567544)
70. Leppik IE, Brodie MJ, Saetre ER et al. Outcomes research: clinical trials in the elderly. Epilepsy Res. 68(Suppl. 1), S71-S76 (2006).
71. Baker GA, Jacoby A, Buck D et al. The quality of life of older people with epilepsy: fndings from a UK community study. Seizure 10, 92-99 (2001).
72. Pugh MJ, Copeland LA, Zeber JE et al. The impact of epilepsy on health status among younger and older adults. Epilepsia 46(11), 1820-1827 (2005).
73. Baulac M, Pitkanen A. Research priorities in epilepsy for the next decade-a representative view of the European Research Workshop, Brussels, 17-18 January 2008. Epilepsia 50, 571-583 (2009).